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ABSTRACT 
Fungal pathogens represent a significant threat to immunocompromised 
patients or individuals with traumatic injury.  Strategies to efficiently remove 
fungal spores from hospital surfaces and, ideally, patient skin thus offer the 
prospect of dramatically reducing infections in at-risk patients. Photodynamic 
inactivation of microbial cells using light holds considerable potential as a non-
invasive, minimally destructive disinfection strategy.  Recent data indicate that 
high-intensity blue light effectively removes bacteria from surfaces, but its 
efficacy against fungi has not been fully tested.  Here we test a wide range of 
fungi that are pathogenic to humans and demonstrate that blue light is effective 
against some, but not all, fungal species.  We additionally note that secondary 
heating effects are a previously unrecognized confounding factor in establishing 
the antimicrobial activity of blue light.  Thus blue light holds promise for the 
sterilization of clinical surfaces, but requires further optimization prior to 
widespread use.  
 
INTRODUCTION 
Invasive fungal infection is a common secondary complication of 
traumatic injury and can involve a wide-range of fungal species from diverse 
genera such as Candida, Fusarium, Rhizopus and Scedosporium, amongst others 
(1, 13, 14). Fungal spores present in the environment are easily introduced into 
wounds after traumatic injury such as motor vehicle accidents, environmental 
disasters or injuries resulting from military operations (1).  Once established in 
the host, fungal infections are difficult to treat and are associated with high levels 
of morbidity and mortality.  Thus strategies to decolonize hospital surfaces and 
surface-exposed wound tissue hold considerable promise for reducing 
secondary fungal infection.   
Exposing microbes to a range of different light wavelengths, in 
combination with photosensitizing dyes, can effectively inactivate various 
bacteria, mycoplasma and viruses (2). Such a combination is called 
photodynamic therapy (PTD) and has been clinically approved. However, a 
major challenge for PTD is the need to introduce exogenous photosensitizers 
into the pathogen (3).  More recently, however, there has been considerable 
interest in exploiting blue light, which appears to be effective against pathogens 
without the need for exogenous photosensitizers. In particular, Zhang and 
colleagues demonstrated the efficacy of blue light against several pathogens, 
including the intrinsically antimicrobial-resistant species Acinetobacter 
baumannii, in a mouse burn model of infection (3; 4). Importantly, they also 
demonstrated that bacteria are more susceptible to blue light than keratinocytes, 
offering advantages over other currently used topical treatments that are often 
toxic and ineffective. The proposed mechanism behind the action of blue light is 
the photoexcitation of endogenous porphyrins, resulting in the production of 
ROS (Reactive Oxygen Species) and cell death (5), although this has yet to be 
formally demonstrated for most blue-light susceptible organisms.  
 To date, very few fungal species have been tested for sensitivity to blue 
light.  Here we test a range of trauma associated fungal pathogens (1) and show 
that many, but not all, are effectively inactivated by this treatment.  However, we 
also demonstrate that some of the antimicrobial activity previously ascribed to 
blue light may in fact result from secondary heating effects and thus recommend 
a more detailed characterization of this antimicrobial strategy prior to 
widespread adoption. 
 
RESULTS 
Blue light shows antifungal activity against some, but not all, fungal species 
tested 
For most fungal infections the initiating inocula are fungal spores and 
disease progression depends on germination and subsequent hyphal invasion of 
tissue.  We therefore exposed spores of six common trauma-associated fungal 
pathogens (Rhizopus microsporus, Mucor circinelloides, Scedosporium 
apiospermum, Scedosporium prolificans, Fusarium oxysporum, Fusarium solani) to 
blue light treatment and then transferred onto agar plates for CFU counting over 
the following days.  Blue light was highly effective against Scedosporium and 
Fusarium species, but showed no inhibitory effect but rather enhanced survival 
relative to controls on the two species of Mucorales tested (Figure 1 a).  
To test the potential for blue light to decontaminate solid surfaces, we 
inoculated fungal spores onto agar and then treated with blue light for 1 hour at 
room temperature before being allowed to grow for 10 days to determine fungal 
survival and colony morphology. As with treatment in liquid, blue light exposure 
on solid (agar) media was highly effective against Scedosporium and Fusarium 
species, but showed no inhibitory effect on the two species of Mucorales tested 
(Figure 1 b). To ensure that this effect was not related to blue-light induced 
alteration of the agar surface structure, we performed an additional control by 
treating agar plates with blue light for one hour and then inoculating with fungal 
spores, which resulted in normal growth of all fungi tested (Supplementary 
Figure 2).  
 
Germination is permanently blocked in most fungal species, but only 
delayed in Mucorales and Candida 
To visualize blue light effects on fungal pathogens we performed time-
lapse imaging on treated fungal spores and additionally included Candida 
albicans, which has previously been shown to be sensitive to blue light killing (4)  
(Figure 2). Time lapse imaging demonstrated that blue light treatment 
permanently inhibited germination of Scedosporium and Fusarium species, but 
that Rhizopus microsporus, Mucor circinelloides and Candida albicans eventually 
recovered full growth capability.  Thus blue light induces a germination/growth 
arrest that appears permanent in most fungi, but only transient in the Mucorales 
and Candida species tested here.  It will be of interest in the future to establish 
whether this pattern is conserved across the diversity of fungal species within 
these two groups.   
Interestingly, during these studies on Rhizopus microsporus we also made 
the chance observation of a morphological change during germination into yeast-
like budding (Figure 2). Further analysis demonstrated that this budding is 
suppressed by exposure to light (Supplementary Figure 1). Budding of this sort 
has been previously reported for M. circinelloides (6) but never previously 
observed in Rhizopus species, so this observation raises the possibility that 
budding in the absence of light stimuli may be widespread within the Mucorales. 
 
Blue light exposure leads to secondary heating, but this is not a major 
contributor to the growth inhibition effect. 
During our investigations we noted that treated samples were 
significantly warmer than untreated controls.  We therefore measured 
temperature within the medium for samples within the blue light instrument 
that were either exposed to blue light or wrapped within foil.  In both cases, we 
noted a very rapid increase in temperature during instrument operation (Figure 
3).  Such temperatures are likely to be deleterious to fungal spore survival and 
we therefore repeated our blue light treatment experiments by housing the 
instrument within a cold room, which limited the maximum temperature 
experienced to 37° C (Figure 4), a temperature that is fully permissive for growth 
of these pathogens.  When we repeated this assay under these conditions, blue 
light retained its potent inhibitory effect on the Fusarium and Scedosporium 
species and, as before, showed no inhibition of Mucormycete survival (Figure  4).  
 
Blue light is highly effective against pre-germinated spores, but also leads 
to significant cytotoxicity towards mammalian cells 
 In clinical settings, fungal spores might have germinated (or, in the case of 
Candida albicans, switched from yeast to form hyphae in response to 
environmental cues such as the presence of serum, low oxygen or high pH) and 
begun filamentous growth before treatment can be applied. Therefore we 
investigated the effect of blue light treatment on pre-germinated spores and 
hyphae. Spores were first germinated for 3-5 hours, and then exposed to 60 
minutes of blue light (in cold room conditions to limit temperature exposure to 
below 37° C) followed by time-lapse microscopy (Figure 5). In all cases, blue 
light treatment effectively stopped further growth of germ tubes, including in 
Mucormycete species, and Candida hyphae, two fungal groups that show 
resistance to blue light as spores or yeast, respectively (Figure 1). Thus, blue 
light is an effective inhibitory treatment for fungal spores that have already 
germinated, including for species that are resistant to such treatment as spores.   
 Previous work has demonstrated that blue light can also induce high 
levels of cell death in mammalian cells (3).  To test whether this was also the 
case in our system, we J774 murine cells to 15, 30, 45 and 60 min of blue light, 
under conditions where the temperature was controlled to 37oC.  As previously 
reported by others for other cell types, blue light exposure led to a rapid, dose-
dependent cell death in this cell line whilst J774 cells not exposed to blue light 
showed undetectable levels of death over the same time period (Supplementary 
Figure 3).  
 
DISCUSSION 
 Fungal infections are a common complication of traumatic injuries 
sustained in both military and civilian environments like agricultural, motor 
vehicle, and natural disasters or blunt crush injuries (1).  
Here we have tested the most significant trauma-associated fungi, including 
Mucorales, Scedosporium, Fusarium and Candida spp. against blue light therapy. 
Fungal tissue infections are very difficult to treat as many of these species show 
intrinsic resistance to antifungals and drug accessibility to wounded tissue is 
poor.  Thus blue light may represent a novel approach for dealing with such 
infections.  
 We have demonstrated that 60 minutes of blue light treatment, providing 
an equivalent total dosage of 216 J/cm2, shows potent inhibition of fungal 
growth for spores that have already germinated and produced hyphae or germ 
tubes in all species tested. In addition, such an approach can also be an effective 
decontaminant of ungerminated spores for most, but not all, pathogenic species.  
 However, we also note some important caveats to this approach.  Firstly, 
for resistant Mucormycete species, blue light treatment appears to counteract 
the effect of high-temperature and enhance subsequent germination (Figure 1) 
and morphological switching (Figure 2), the immunological consequences of 
which remain unknown.  This likely reflects the previously characterized role of 
blue wavelengths as a regulator of fungal growth (7).  In an analogous context, 
we note that others have previously demonstrated the ability of blue light to 
enhance virulence in selected bacterial pathogens, such as Brucella species (8).  
Thus blue light may inadvertently work against other forms of fungal 
decontamination (such as heat treatment) in resistant species. Secondly, we note 
that the high-intensity blue light system used here generates considerable heat - 
a factor that is important to control for when assessing its efficacy against 
pathogenic microbes.  The extent to which secondary heating occurs with other 
blue light instruments is unknown, but should be borne in mind as a potential 
confounding factor in other studies.  Lastly, although (unlike ultraviolet) blue 
light is not mutagenic (12), both our own studies (Supplementary Figure 3) and 
previous work (3) demonstrate relatively high levels of toxicity for blue light 
against some mammalian cells - an observation that may limit the application of 
this approach directly to patients.  Thus blue light offers a potentially useful 
antimicrobial approach, but its toxicity towards mammalian cells and its limited 
efficacy against some fungal spores may suggest it is more appropriately used as 
a selective surface decontaminant than an in vivo antifungal.     
 
MATERIALS AND METHODS 
Fungal strains. Eight different strains were tested: Rhizopus microsporus 
12.6652333 and Mucor circinelloides NRRL3631 (10), Scedosporium 
apiospermum IHEM 14462, Scedosporium prolificans IHEM 5608, Fusarium 
oxysporum IHEM 25499, Fusarium solani IHEM 6092, all from the Belgian 
Coordinated Collections of Microorganisms, as well as Candida albicans SN152 
(11). Mucorale strains were grown on Sabouraud agar plates, Scedosporium and 
Fusarium spp. were grown on Potato Glucose agar plates for at least 10 days 
before use at room temperature, and Candida was grown on Yeast Extract 
Peptone agar plates for 1 day at 37° C.  
Media. Spores were washed off agar plates with phosphate-buffered 
saline (PBS) (Fisher Scientific), then spun down and resuspended in PBS for cell 
counting in a haemocytometer.  For Candida species, a single yeast colony was 
picked from YPD agar using an inoculation loop and inoculated in YPD or RPMI 
broth (depending on the experiment) for counting in a haemocytometer. For 
blue light testing, fungal spores and cells were inoculated into PBS and exposed 
to blue light, then transferred to appropriate agar plates after treatment for 
subsequent colony counting. For microscopy experiments, fungal spores and 
cells were inoculated in Sabouraud broth (Sigma Aldrich).  
Temperature measurement. The temperature of treated cell cultures 
was measured within 24 well plates using a submersible aquarium thermometer 
(ETI, UK). The temperature was recorded constantly throughout the treatment 
and plotted at five minutes intervals. This temperature measurement was 
repeated on three separate occasions over of period of three months, with 
extremely consistent data on each occasion.  
Treatment with blue light. A LED flood array (9), composed of 144 LEDs 
(Henkel-Locite, Hemel Hampstead, UK), was used to treat a 10 x 10 cm area 
using high-intensity blue light (405 nm).  All experiments on fungal cells were 
performed by placing samples within the treatment area for 1 hour, providing an 
equivalent total dosage of 216 J/cm2.  To control for temperature effects, 
experiments were either performed in a cold room (4° C) or at room 
temperature, as described.  Fungal cells were inoculated into PBS and then 
placed under the treatment area for 60 minutes (216 J/cm2). Two control 
conditions were used: one plate covered with aluminum foil inside the blue light 
machine (exposed to temperature, but not blue light, effects) and one kept 
outside the instrument during operation (not exposed to either raised 
temperatures or blue light). Following treatment, each fungal suspension was 
transferred onto appropriate agar plates and CFU numbers were counted 
following growth (typically a few days later). Each experiment was performed in 
technical triplicate and repeated on at least three occasions. For determining an 
effect of blue light on fungal morphology assay, fungal spores were inoculated 
onto agar and treated with blue light for 1 hour in the room temperature then 
left to grow for a few days, or agar plates were treated with blue light for 1 hour, 
then fungal spores/cells were inoculated on it for growth. For determining blue 
light cytotoxicity, the murine cell line J774 was treated with blue light for 15, 30, 
45 and 60 min in cold room to control for excessive heating. Following treatment 
cells were stained with Trypan blue for viability and counted using a 
haemocytometer to determine percentage survival (Supplementary Figure 3). 
J774 cell line was incubated in complete DMEM (Sigma-Aldrich), phenol free, 
plus 100U/ ml of penicillin and 100 U/ ml of streptomycin (Sigma), 2 mM l- 
glutamine (Sigma), and 10% fetal bovine serum (FBS) (Sigma) in 37°C and CO2 
condition.  
Time-lapse imaging. Time-lapse imaging was performed on fungal 
spores immediately after treatment with blue light, using a Nikon Eclipse Ti 
microscope with a long working distance (LWD) 0.53 20 x objective for 18 h with 
5 min intervals.  Movies for publication were analysed and prepared in NIS 
Element software.  
Light controls for R. microsporus. Light controls for R. microsporus and 
M. circinelloides NRRL3631 were performed on fungal spores that were washed 
off the agar plates, inoculated in Sabouraud broth (Sigma Aldrich) and covered 
with aluminum foil or exposed to light. Plates were incubated at room 
temperature for 10 hours and samples were taken for pictures. 
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FIGURES: 
 
FIG 1. 60 min (216 J/cm2) blue light treatment of fungal spores. Spores were 
inoculated in PBS treated with blue light and then plated onto appropriate agar 
plates for enumeration (A).  Alternatively, 1000 spores were plated onto agar 
and then exposed to blue light for 60 minutes before being incubated for growth 
(B) Error bars represent standard deviation (n= 3, with three experimental 
replicates) One-way ANOVA followed by Tukey’s multiple comparisons test 
shows significant difference (p < 0.05 for all comparisons) in blue light treatment 
survival between R. microsporus and M. circinelloides and other species tested. B) 
represent images of fungal growth on agar plates following blue light treatment. 
 
FIG 2. Visualization of blue light effect on fungal spores and cells. Time-lapse 
imaging shows that blue light 60 min treatment (216 J/cm2) under controlled 
temperature conditions is effective against S. prolificans and F. solani species but 
not C. albicans or Mucorales.  
 
FIG 3. Temperature rises rapidly inside the blue light instrument during 
operation. Incubating samples on ice within the instrument is insufficient to 
reduce this effect, but housing the instrument within a cold room (at 4° C) during 
treatment maintains sample temperatures at 37° C. 
 
FIG 4. 60 min (216 J/cm2) blue light treatment of fungal spores in cold room 
conditions shows similar growth inhibition effects. Spores were inoculated in 
PBS and treated with blue light before plating for growth and CFU enumeration.  
Error bars represent standard deviation (n= 3, with three experimental 
replicates). One-way ANOVA followed by Tukey’s multiple comparisons test 
shows significant difference (p < 0.05 for all comparisons) in blue light treatment 
survival between R. microsporus and M. circinelloides and other species tested. 
 
FIG. 5. 60 min (216 J/cm2) blue light treatment show antifungal activity on 
pregerminated spores. Time-lapse imaging shows inhibition of further fungal 
growth after blue light treatment.  
 
 
 





